BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Lynk Pharma's LNK01001 Shows Positive Results in Ankylosing Spondylitis Phase II Trial

The study, led by Professor Xiaofeng Zeng, the director of the Department of Rheumatology and Immunology of Peking Union Medical College Hospital and ...

August 23, 2023 | News

MGI Partners with NGeneBio to Advance Precision Medicine

This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...

August 23, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

August 22, 2023 | Regulatory

Bruker to Acquire PhenomeX in All-Cash Deal

Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) announced that they have signed a definitive agreement for Bruker to acquire Pheno...

August 21, 2023 | News

Nagasaki University & NEC OncoImmunity Partner for Universal Vaccines Against Tropical Diseases

The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...

August 21, 2023 | News

Breakthrough 'eAir' Aero-Elastic Pressure Sensor from NUS Set to Revolutionize Medical Implants and Surgeries

The eAir sensor promises increased precision and reliability across medical applications. It can potentially transform laparoscopic surgeries by enabling t...

August 19, 2023 | News

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

Minghui Pharma Enrolls First Patient in Phase 3 Study for MH004 Cream in Atopic Dermatitis

The phase 3 clinical trial aims to evaluate the safety and efficacy of the investigational topical cream in a larger patient population. Leveraging the con...

August 18, 2023 | News

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...

August 17, 2023 | News

Parexel & Partex Unite Artificial Intelligence and Big Data to Speed Drug Discovery

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, a...

August 16, 2023 | News

Infinitus & Jiangnan University Create Center for Herbal Medicine-Probiotic Combo

Lam Yu, CEO of Infinitus Global and Vice Chairman of Infinitus (China), expressed his enthusiasm in his speech, "Infinitus has been deeply involved in th...

August 16, 2023 | News

Kelun-Biotech's Phase III Trial of SKB264 Meets Endpoint in Advanced TNBC

Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...

August 15, 2023 | News

Sunbird Bio Joins Glympse Bio to Advance Protein-Based Diagnostics

Combined company will operate as Sunbird Bio and focus on advancing clinical-stage platforms with demonstrated potential to enhance patient care in A...

August 14, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

August 11, 2023 | News

Stay Connected